CME Radiology Grand Rounds
When:
2nd & 4th Fridays, 12:00pm - 1:00pm
Exceptions:
5/3/24 & 5/17/24 will be the 1st & 3rd Friday of the month.
The Moskowitz Lectureship will be on the first Thursday, 11/2/23, from 5:30-6:30pm.
Where:
Li Ka Shing Learning and Knowledge Center & Zoom.
Zoom link:
https://stanford.zoom.us/j/91767596068?pwd=aTRUVEc3K28wcHFsQ3UxUXQ5T05Hdz09
2023 - 2024 Schedule
April
Friday, April 12, 2024
12:00-1:00PM | LK120 & Zoom
Theranostics, the age of Enlightenment
Radiotheranostics are a unique type of cancer drugs which enable simultaneous imaging and therapy. Theranostics can be used to visually assess the biodistribution of the radiopharmaceutical and for the selection of patients to receive the therapeutic drug (which can be described as ‘seeing what you treat’). Thus, theranostics help reducing the risks of failure associated with drug development, by allowing the visualization and quantification of both the presence and engagement of the target. Old and recent clinical successes achieved thus far, particularly in neuroendocrine tumors and prostate cancer, go in parallel with the development of challenges associated with the effective and widespread deployment of new agents, as well as their future potential and emerging opportunities.
One of the major challenges in this field is the relatively short duration of treatment response. Several new strategies to improve the efficacy and tolerability of radiotheranostics have been proposed. Among these, the use of alpha emitters is very promising to overcome the intrinsic radioresistance of cancer cells. Also, equally important, is the individualization treatments based on the specific dosimetric estimates for the tumor and normal organs, as well as the determination of tissue radiosensitivity.
Learning objectives
On successful completion of this activity, participants should be able to describe
- The application of theranostics in neuroendocrine tumors and prostate cancer.
- The approved radiopharmaceuticals and their efficacy and tolerability profile.
- New strategies for the improvement of the treatment response.
Friday, April 26, 2024
12:00-1:00PM | LK130 & Zoom
Going for Broke: Imaging of Cardiothoracic Trauma
This seminar will focus on the imaging findings in cardiothoracic trauma with emphasis on a location based approach and the use of direct and indirect signs. Penetrating trauma will also be discussed.
Session Learning Objectives
- Highlight the concept of direct vs indirect signs in Cardiothoracic Trauma Imaging
- Discuss the understanding the value of points of differential deceleration
- Emphasize how blunt and penetrating trauma may vary in their appearances